Related Experiment Video
Updated: May 29, 2026
05:57
The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
Antihypertensive effects of astaxanthin
Hidekatsu Yanai1, Kumie Ito, Hiroshi Yoshida
1Department of Internal Medicine;
Integrated Blood Pressure Control
|September 28, 2011
Summary
Astaxanthin, a natural antioxidant, significantly lowers blood pressure and reduces vascular remodeling in hypertensive rats. Further research is warranted to explore its antiatherogenic potential.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Nutraceutical Science
Background:
- Astaxanthin is a potent antioxidant found in aquatic organisms.
- It exhibits anti-inflammatory and antidiabetic properties.
- Preliminary studies suggest astaxanthin may possess antihypertensive effects.
Purpose of the Study:
- To investigate the antihypertensive effects of astaxanthin.
- To explore astaxanthin's impact on vascular remodeling in hypertension.
- To evaluate astaxanthin's potential role in preventing atherosclerosis.
Main Methods:
- Administration of astaxanthin to stroke-prone spontaneously hypertensive rats.
- Assessment of blood pressure and stroke incidence.
- Ex vivo studies using aortic rings from spontaneously hypertensive rats.
- Histopathological examination of coronary artery wall thickness.
Main Results:
- Astaxanthin administration led to a significant reduction in blood pressure.
- It delayed the incidence of stroke in the studied rat model.
- Astaxanthin reduced aortic contractile responses to vasoconstrictors.
- Coronary artery wall thickness was decreased by astaxanthin treatment.
Conclusions:
- Astaxanthin demonstrates significant antihypertensive effects.
- It may ameliorate hypertension-induced vascular remodeling.
- Further studies are needed to confirm its antiatherogenic properties.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:24Antiasthma Drugs: Methylxanthines
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...